MDACC Study No:2005-0825 ( NCT No: NCT00410189)
Title:A Phase II, Open Label Study of ZD6474 in Previously Treated Subjects with Advanced Non-Small Cell Lung Cancer
Principal Investigator:Anne S. Tsao
Treatment Agent:ZD6474
Study Status:Terminated
Study Description:The goal of this clinical research study is to learn if ZD6474 can help to
control NSCLC. The safety of this drug will also be studied, as well as the
drug's effect on different cells in the body and the participants' overall
Hide details for General InformationGeneral Information

Disease Group:Lung
Phase of Study:Phase II
Treatment Agents:ZD6474
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:N/A
Supported By:N/A
Return Visit:Participants will return to the clinic at weeks 1, 2, 4, 8, 12, then every
cycle thereafter.
Home Care:N/A

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Anne S. Tsao
Dept:Thoracic and Head and Neck Med
For Clinical Trial Enrollment:713-792-6363
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults